ResMed Total Liabilities 2010-2025 | RMD
ResMed total liabilities from 2010 to 2025. Total liabilities can be defined as the total value of all possible claims against the corporation.
- ResMed total liabilities for the quarter ending March 31, 2025 were $2.021B, a 7.5% decline year-over-year.
- ResMed total liabilities for 2024 were $2.008B, a 23.4% decline from 2023.
- ResMed total liabilities for 2023 were $2.622B, a 51.1% increase from 2022.
- ResMed total liabilities for 2022 were $1.735B, a 5.83% decline from 2021.
| ResMed Annual Total Liabilities (Millions of US $) |
|
|---|---|
| 2024 | $2,008 |
| 2023 | $2,622 |
| 2022 | $1,735 |
| 2021 | $1,842 |
| 2020 | $2,090 |
| 2019 | $2,035 |
| 2018 | $1,005 |
| 2017 | $1,508 |
| 2016 | $1,562 |
| 2015 | $594 |
| 2014 | $603 |
| 2013 | $600 |
| 2012 | $530 |
| 2011 | $338 |
| 2010 | $339 |
| 2009 | $393 |
| ResMed Quarterly Total Liabilities (Millions of US $) |
|
|---|---|
| 2025-03-31 | $2,021 |
| 2024-12-31 | $1,888 |
| 2024-09-30 | $2,027 |
| 2024-06-30 | $2,008 |
| 2024-03-31 | $2,185 |
| 2023-12-31 | $2,423 |
| 2023-09-30 | $2,490 |
| 2023-06-30 | $2,622 |
| 2023-03-31 | $2,781 |
| 2022-12-31 | $2,938 |
| 2022-09-30 | $1,745 |
| 2022-06-30 | $1,735 |
| 2022-03-31 | $1,626 |
| 2021-12-31 | $1,589 |
| 2021-09-30 | $1,703 |
| 2021-06-30 | $1,842 |
| 2021-03-31 | $1,876 |
| 2020-12-31 | $1,708 |
| 2020-09-30 | $1,942 |
| 2020-06-30 | $2,090 |
| 2020-03-31 | $2,254 |
| 2019-12-31 | $2,096 |
| 2019-09-30 | $2,037 |
| 2019-06-30 | $2,035 |
| 2019-03-31 | $2,077 |
| 2018-12-31 | $1,904 |
| 2018-09-30 | $1,167 |
| 2018-06-30 | $1,005 |
| 2018-03-31 | $1,467 |
| 2017-12-31 | $1,544 |
| 2017-09-30 | $1,440 |
| 2017-06-30 | $1,508 |
| 2017-03-31 | $1,568 |
| 2016-12-31 | $1,612 |
| 2016-09-30 | $1,550 |
| 2016-06-30 | $1,562 |
| 2016-03-31 | $771 |
| 2015-12-31 | $715 |
| 2015-09-30 | $794 |
| 2015-06-30 | $594 |
| 2015-03-31 | $742 |
| 2014-12-31 | $738 |
| 2014-09-30 | $656 |
| 2014-06-30 | $603 |
| 2014-03-31 | $674 |
| 2013-12-31 | $707 |
| 2013-09-30 | $642 |
| 2013-06-30 | $600 |
| 2013-03-31 | $607 |
| 2012-12-31 | $579 |
| 2012-09-30 | $546 |
| 2012-06-30 | $530 |
| 2012-03-31 | $520 |
| 2011-12-31 | $480 |
| 2011-09-30 | $386 |
| 2011-06-30 | $338 |
| 2011-03-31 | $299 |
| 2010-12-31 | $273 |
| 2010-09-30 | $315 |
| 2010-06-30 | $339 |
| 2010-03-31 | $381 |
| 2009-12-31 | $364 |
| 2009-09-30 | $417 |
| 2009-06-30 | $393 |
| 2009-03-31 | $353 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $37.259B | $4.685B |
| ResMed, Inc. holds a major position as designer, manufacturer, as well as a distributor in the worldwide market for generators, masks, and related accessories for the treatment of sleep-disordered breathing (SDB) and other respiratory disorders. SDB includes obstructive sleep apnea (OSA) and other respiratory disorders that occur during sleep. The company currently has two operating segments, which are the Sleep and Respiratory Care segment and the Software-as-a-Service segment. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $229.711B | 27.62 |
| Boston Scientific (BSX) | United States | $154.351B | 38.64 |
| Stryker (SYK) | United States | $149.416B | 31.24 |
| EssilorLuxottica (ESLOY) | France | $132.057B | 0.00 |
| Medtronic (MDT) | Ireland | $115.083B | 16.32 |
| Lonza Group Ag (LZAGY) | Switzerland | $49.624B | 0.00 |
| Haleon (HLN) | United Kingdom | $44.474B | 25.39 |
| Agilent Technologies (A) | United States | $34.110B | 22.24 |
| GE HealthCare Technologies (GEHC) | United States | $34.090B | 16.18 |
| Terumo (TRUMY) | Japan | $24.459B | 31.77 |
| Koninklijke Philips (PHG) | Netherlands | $23.149B | 16.24 |
| Insulet (PODD) | United States | $20.550B | 80.67 |
| Zimmer Biomet Holdings (ZBH) | United States | $18.570B | 11.93 |
| Baxter (BAX) | United States | $14.641B | 10.93 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $13.157B | 0.00 |
| Demant (WILYY) | Denmark | $8.633B | 0.00 |
| Sunny Optical Technology (SNPTF) | China | $8.561B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $6.825B | 23.75 |
| Lantheus Holdings (LNTH) | United States | $5.747B | 14.50 |
| Prestige Consumer Healthcare (PBH) | United States | $3.776B | 16.87 |
| Perrigo (PRGO) | Ireland | $3.768B | 9.55 |
| Haemonetics (HAE) | United States | $3.683B | 16.77 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $3.459B | 0.00 |
| Envista Holdings (NVST) | United States | $3.395B | 28.21 |
| ICU Medical (ICUI) | United States | $3.220B | 23.75 |
| QuidelOrtho (QDEL) | United States | $1.952B | 13.42 |
| LeMaitre Vascular (LMAT) | United States | $1.900B | 42.47 |
| AtriCure (ATRC) | United States | $1.550B | 0.00 |
| Acuren (TIC) | United States | $1.455B | 0.00 |
| Green Thumb Industries (GTBIF) | United States | $1.374B | 30.91 |
| Phibro Animal Health (PAHC) | United States | $1.278B | 16.34 |
| AdaptHealth (AHCO) | United States | $1.237B | 12.56 |
| Neogen (NEOG) | United States | $1.133B | 14.50 |
| BioLife Solutions (BLFS) | United States | $1.053B | 0.00 |
| InMode (INMD) | Israel | $0.932B | 9.39 |
| Kestra Medical Technologies (KMTS) | United States | $0.792B | 0.00 |
| Curaleaf Holdings (CURLF) | Canada | $0.749B | 0.00 |
| Maravai LifeSciences Holdings (MRVI) | United States | $0.680B | 0.00 |
| Tilray Brands (TLRY) | Canada | $0.661B | 0.00 |
| Owens & Minor (OMI) | United States | $0.616B | 5.11 |
| Evolus (EOLS) | United States | $0.613B | 0.00 |
| CeriBell (CBLL) | United States | $0.592B | 0.00 |
| Valneva SE (VALN) | France | $0.517B | 0.00 |
| Surmodics (SRDX) | United States | $0.449B | 0.00 |
| SNDL (SNDL) | Canada | $0.415B | 0.00 |
| Capricor Therapeutics (CAPR) | United States | $0.337B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.327B | 12.02 |
| Sanuwave Health (SNWV) | United States | $0.310B | 0.00 |
| Cresco Labs (CRLBF) | United States | $0.306B | 0.00 |
| SEMPERIT AG HLD (SEIGY) | Austria | $0.304B | 0.00 |
| Quanterix (QTRX) | United States | $0.302B | 0.00 |
| Cerus (CERS) | United States | $0.277B | 0.00 |
| Viemed Healthcare (VMD) | United States | $0.266B | 22.40 |
| Aurora Cannabis (ACB) | Canada | $0.257B | 76.33 |
| Sanara MedTech (SMTI) | United States | $0.257B | 0.00 |
| ZimVie (ZIMV) | United States | $0.249B | 11.30 |
| Brainsway (BWAY) | Israel | $0.231B | 61.17 |
| Omeros (OMER) | United States | $0.230B | 0.00 |
| OraSure Technologies (OSUR) | United States | $0.230B | 0.00 |
| Verano Holdings (VRNOF) | United States | $0.226B | 0.00 |
| Biote (BTMD) | United States | $0.221B | 6.22 |
| Canopy Growth (CGC) | Canada | $0.215B | 0.00 |
| Organigram Global (OGI) | Canada | $0.198B | 0.00 |
| High Tide (HITI) | Canada | $0.195B | 0.00 |
| TriSalus Life Sciences (TLSI) | United States | $0.188B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.184B | 15.00 |
| Vireo Growth (VREOF) | United States | $0.162B | 0.00 |
| Exagen (XGN) | United States | $0.151B | 0.00 |
| FitLife Brands (FTLF) | United States | $0.123B | 15.13 |
| TerrAscend (TSNDF) | Canada | $0.115B | 0.00 |
| Fonar (FONR) | United States | $0.101B | 13.05 |
| MacroGenics (MGNX) | United States | $0.100B | 0.00 |
| Jin Medical (ZJYL) | China | $0.094B | 0.00 |
| Jushi Holdings (JUSHF) | United States | $0.092B | 0.00 |
| Veru (VERU) | United States | $0.089B | 0.00 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.087B | 0.00 |
| Quipt Home Medical (QIPT) | United States | $0.083B | 0.00 |
| Apyx Medical (APYX) | United States | $0.074B | 0.00 |
| InterCure (INCR) | Israel | $0.071B | 0.00 |
| Agape ATP (ATPC) | $0.069B | 0.00 | |
| Cytosorbents (CTSO) | United States | $0.066B | 0.00 |
| Zynex (ZYXI) | United States | $0.064B | 0.00 |
| ImmuCell (ICCC) | United States | $0.059B | 0.00 |
| Nephros (NEPH) | United States | $0.040B | 54.00 |
| Safety Shot (SHOT) | United States | $0.040B | 0.00 |
| Modular Medical (MODD) | United States | $0.039B | 0.00 |
| Rockwell Medical (RMTI) | United States | $0.038B | 0.00 |
| United-Guardian (UG) | United States | $0.037B | 12.87 |
| Allurion Technologies (ALUR) | United States | $0.021B | 0.00 |
| Flora Growth (FLGC) | United States | $0.016B | 0.00 |
| INLIF (INLF) | $0.015B | 0.00 | |
| Meihua Medical Technologies (MHUA) | China | $0.014B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.013B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.013B | 0.00 |
| Senestech (SNES) | United States | $0.011B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.009B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.007B | 0.00 |
| Sharps Technology (STSS) | United States | $0.006B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.003B | 0.00 |
| Akanda (AKAN) | Canada | $0.002B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.000B | 0.00 |